Literatur

American Society of Microbiology: FAQ: http://academy.asm.org/index.php/faq-series/5122-humanmicrobiome (2014)

Bearfield, C. et al.: Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG. 109(5):527–533 (2002)

Berger et al.: Empfehlungen zur Prävention und Therapie von Termin- und knapp frühgeborenen Kindern (> 34 SSW) mit erhöhtem Risiko einer perinatalen bakteriellen, Revidierte Empfehlungen der Schweizerischen Gesellschaft für Neonatologie in Zusammenarbeit mit der Pädiatrischen Infektiologiegruppe Schweiz (PIGS). Pediatrica. 2013: 24(1): 11–13. http://www.swiss-paediatrics.org/sites/default/files/empfehlungen/empfehlungen/pdf/11-13.pdf (2013)

Bruins, M. J. et al.: Association between group A beta-haemolytic streptococci and vulvovaginitis in adult women: a case-control study. Acta Obstet Gynecol Scand. 88(9): 958–67. doi: 10.1080/00016340903176800 (2009)

Castellheim, A. et al.: Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis, Scandinavian Journal of Immunology 69, 479–491 (2009)

Center for Disease Control/CDC (Gesundheitsbehörde der USA): Guidelines for the Prevention of Perinatal Group B Streptococcal Disease. MMWR. 59: 1–32, http://www.cdc.gov/groupbstrep/guidelines/guidelines.html (2010)

Crea, P. et al.: Innate immune inflammatory response to danger: when, how, and why does a friend become a foe? Eur Heart J. http://eurheartj.oxfordjournals.org/content/early/2012/02/22/eurheartj.ehs033.full (2012)

Dinsmoor, M. J. et al.: Use of intrapartum antibiotics and the incidence of postnatal maternal and neonatal yeast infections. Obstetrics and gynecology. 106 (1): 19–22 (2005)

Doare, K.: An overview of global GBS epidemiology. Vaccine. 31S: D7–D12 (2013)

Douvier, S. et al.: Chorioamnionitis with intakt membranes caused by Capnoytophaga sputigena. Eur J Obst Gyn Reprod Biol. 83(1):109–112) (1999)

Edwards, M. et al.: Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine 31S:D66–D71 (2013)

El Helali, N. et al.: Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstetrics and Gynecology. 119(4): 822–829 (2012)

Feigin, R. D. et al.: Textbook of Pediatric Infectious Diseases. Saunders (2009)

Fernández, l. et al.: The human milk microbiota: origin and potential role in health and disease. Pharmacological Research. 69: 1–10 (2013)

Goldenberg, R. L. et al.: Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstetrics and Gynecology. 107(5): 1139–1146 (2006)

Human Microbiom Project Consortium: Structure function and diversity of the healthy microbiom. Nature. 486 (7402): 207–214A. http://commonfund.nih.gov/hmp/index, www.nature.com/nature/focus/humanmicrobiota (2012)

Jäger, H.: Mütterliche Mikroflora – Zwiesprache der Bakterien, DHZ. (2): 67–71 (2014)

Johri, A. K. et al.: Group B Streptokoccus: global incidence and vaccine development. Nat Rev Microbiol 4(12): 932–42, CDC (2010) Prevention of perinatal group b streptococcal disease. MMWR 59: 1-32 (2006)

LaTunga, M. S. et al.: A Review of the Source and Function of Microbiota in Breast Milk. Semin Reprod Med. 32: 68–78 (2014)

Marrow, A.: Earlymicrobial and metabolic signatures predict later onset of necrotising enterocolitis in preterms infants, Microbiome. 1:13, www.microbiomejournal.com/content/1/1/13) (2013)

Ohlsson, A. et al.: Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. Jul 8;(3):CD007467. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007467.pub2/abstract;
sessionid=BF6736C7EA74DBFEB089DB8342EA5C1E.f02t04 (2009)

Polin, R. et al.: Management of Neonates With Suspected or Proven Early-Onset Bacterial. Pediatrics. 129; 1006, http://pediatrics.aappublications.org/content/129/5/1006 (2012)

Prince, A. L. et al.: The Microbiome and Development: a mothers perspective. Semin Reprod Med. 32: 14–22 (2014)

Ronnqvist, P. D. et al.: Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand. 85(6): 726–735 (2006)

Schrag, S. J. et al.: A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 347(4): 233–239 (2002)

Shah, B. et al.: Neonatal sepsis. An old problem with new insights. Virulence. 5(1): 170–78 (2014)

Shubin, N. J.: Anti-Inflammatory Mechanisms of Sepsis. In: Herwald, H. (Hrsg.): Sepsis – Pro- Inflammatory and Anti- Inflammatory Responses. Contrib Microbiol. Basel. Karger. vol 17, pp 108–124 (2011)

Stokholm, J. et al.: Antibiotic use during pregnancy alters commensal vaginal microbiota, Clin Microbiol Infect. Oct 1. doi: 10.1111/14690691.12411. [Epub ahead of print], PDF: www.copsac.com/userfiles/2012%20Jakob%20Stokholm%20Thesis.pdf (2013)

Stoll, B. et al.: Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues, Pediatrics. 127(5): 817–826. www.ncbi.nlm.nih.gov/pmc/articles/PMC3081183 (2011)

Tudela, C. M. et al.: Intrapartum evidence of early-onset group B streptococcus." Obstetrics and gynecology. 119(3): 626–629 (2012)

Valkenburg-van den Berg, A. et al.: Association between colonization with Group B Streptococcus and preterm delivery: a systematic review. Acta obstetricia et gynecologica Scandinavica. 88(9): 958–967 (2009)

Vincent, J. L. et al.: (2013): Sepsis definitions: time for change. Lancet. 381: 774–75 (2013)

Young, B. C. et al.: Evaluation of a rapid, real-time intrapartum group B streptococcus assay. Am J Obstet Gynecol. 205(4): 372 e371–376 (2011)